From about 1,000 square feet in a business incubator, antibiotic developer Forge Therapeutics has moved to a 7,000 square-foot headquarters. The tiny La Jolla [...]
-Presentation will focus on Forge’s portfolio of four novel classes of antibiotics to treat deadly ‘superbug’ infections from Gram-negative bacteria- San Diego, California, [...]
On Monday, local leaders converged to celebrate a true San Diego success story: Forge Therapeutics. The biotech startup is doubling its local footprint [...]
Forge Co-founder Presents New Approaches to Treat Infections at the 255th American Chemical Society National Meeting
San Diego, California, March 19, 2018 – Forge Therapeutics, Inc. (Forge), a biotechnology company developing novel medicines targeting metalloenzymes, today announced that Professor [...]
-"What it Means to be Handcrafted in San Diego" Open House Event to Commemorate New Space- San Diego, California, March 12, 2018 – Forge [...]
Emerging Company Profile: Forge Therapeutics, which licensed intellectual property from the University of California San Diego in 2015...
In the pharmaceutical industry, the “batting average” for taking a compound from discovery to a marketed therapy leaves a lot to be desired.
Did you know that the greatest public transportation systems in the world have a direct and important connection to San Diego? The ticketing [...]
Forge Therapeutics and collaborators from Evotec and USC present new efficacy data at 2017 Keystone Symposia Conference
-Data demonstrates broad applicability for LpxC inhibitor in Acinetobacter baumannii, a life-threatening respiratory bacteria- LpxC antibiotic is Forge’s flagship program stemming from BLACKSMITH [...]